Avatar - Markets Insider
Markets Insideradded this to Markets Insider
Avatar - Business Insider
Avatar - Business Insider

Tumors

Roche: FDA Grants Priority Review To Entrectinib

Business Insider - RTTNews

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) said Tuesday that the U.S. Food and Drug Administration has accepted the company's New Drug Applications or NDAs and granted Priority Review for the company's personalised medicine entrectinib. Entrectinib was granted priority review for the …

View on businessinsider.com